4//SEC Filing
Posner Christopher 4
Accession 0001415889-24-020605
CIK 0001346830other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:05 PM ET
Size
5.1 KB
Accession
0001415889-24-020605
Insider Transaction Report
Form 4
Posner Christopher
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2024-08-01$0.35/sh−4,149$1,452→ 172,436 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001748265
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:05 PM ET
- Size
- 5.1 KB